Molecular mechanism of miR-34b-5p and RNA binding protein HuR binding to lncRNA OIP5-AS1 in colon cancer cells

被引:16
|
作者
Wang, Yan [1 ]
Lin, Changkun [2 ]
Liu, Yang [2 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Gastroenterol, Shenyang 110004, Liaoning, Peoples R China
[2] China Med Univ, Coll Basic Med Sci, Shenyang 110122, Liaoning, Peoples R China
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; TUMOR-GROWTH; METASTASIS; EXPRESSION; MICRORNA;
D O I
10.1038/s41417-021-00342-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Colon cancer (CC) is a leading cause of cancer-related death. Long non-coding RNA OIP5-AS1 (lncRNA OIP5-AS1) expression pattern has been studied in many cancers. We aimed to identify the mechanism of lncRNA OIP5-AS1 in CC development. OIP5-AS1 expression pattern in CC tissues and cells was detected and the relation between OIP5-AS1 level and CC prognosis was analyzed. The proliferation, migration and invasion of CC cells were detected after silencing or overexpression of OIP5-AS1. Tumor xenograft in nude mice was established to verify the effect of OIP5-AS1 in vivo. The interaction between HuR protein and OIP5-AS1 and the interaction of miR-34b-5p with HuR and OIP5-AS1 were measured. OIP5-AS1 was highly expressed in CC and associated with poor prognosis. Silencing OIP5-AS1 inhibited CC cell malignant behaviors and inhibited the growth rate and tumor weight. In the mechanism, HuR bound to OIP5-AS1 and stabilized OIP5-AS1 expression. Both miR-34-5p and HuR bind to OIP5 and oppositely affect its expression. miR-34b-5p inhibited the proliferation and invasion of CC cells by inhibiting OIP5-AS1 and PI3K/Akt pathway. miR-34b-5p inhibited CC growth by inhibiting OIP5-AS1. Collectively, miR-34b-5p targets HuR and miR-34b-5p binds to OIP5-AS1 with HuR, thus inhibiting OIP5-AS1 and PI3K/Akt pathway and CC progression.
引用
收藏
页码:612 / 624
页数:13
相关论文
共 50 条
  • [1] Molecular mechanism of miR-34b-5p and RNA binding protein HuR binding to lncRNA OIP5-AS1 in colon cancer cells
    Yan Wang
    Changkun Lin
    Yang Liu
    Cancer Gene Therapy, 2022, 29 : 612 - 624
  • [2] LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR
    Kim, Jiyoung
    Abdelmohsen, Kotb
    Yang, Xiaoling
    De, Supriyo
    Grammatikakis, Ioannis
    Noh, Ji Heon
    Gorospe, Myriam
    NUCLEIC ACIDS RESEARCH, 2016, 44 (05) : 2378 - 2392
  • [3] LncRNA OIP5-AS1 promotes the development of esophageal squamous cell carcinoma by binding to miR-1297
    Wang, Li
    Ren, Xiaoxia
    Ma, Xiaoyan
    Yin, Lizhi
    Niu, Xinqing
    Xing, Shouli
    PANMINERVA MEDICA, 2022, 64 (04) : 589 - 590
  • [4] LncRNA OIP5-AS1 Targets the miR-140-5p/UBR5 Cascade to Promote the Development of Gastric Cancer
    Liu, Mei
    Song, Xiujun
    Sun, Yinyin
    Zhang, Tieshan
    MOLECULAR BIOTECHNOLOGY, 2024, 66 (12) : 3583 - 3596
  • [5] LncRNA OIP5-AS1 Promotes Breast Cancer Progression by Regulating miR-216a-5p/GLO1
    Wu, Zizheng
    Liu, Yinfeng
    Wei, Liguang
    Han, Meng
    JOURNAL OF SURGICAL RESEARCH, 2021, 257 : 501 - 510
  • [6] LncRNA OIP5-AS1 INDUCES EPITHELIAL-TO-MESENCHYMAL TRANSITION AND RENAL FIBROSIS IN DIABETIC NEPHROPATHY VIA BINDING TO miR-30c-5p
    Fu, J-X
    Sun, G-Q
    Wang, H-L
    Jiang, H-X
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (03): : 961 - 968
  • [7] LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells
    Zou, Yanmei
    Yao, Shuo
    Chen, Xiuqiong
    Liu, Dian
    Wang, Jianhua
    Yuan, Xun
    Rao, Jie
    Xiong, Huihua
    Yu, Shiying
    Yuan, Xianglin
    Zhu, Feng
    Hu, Guohong
    Wang, Yihua
    Xiong, Hua
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2018, 97 (05) : 369 - 378
  • [8] LncRNA OIP5-AS1 accelerates intervertebral disc degeneration by targeting miR-25-3p
    Che, Zhaoping
    Jie Xueqin
    Zhang, Zongyu
    BIOENGINEERED, 2021, 12 (02) : 11201 - 11212
  • [9] LncRNA OIP5-AS1 Promotes the Proliferation of Hemangioma Vascular Endothelial Cells via Regulating miR-195-5p/NOB1 Axis
    Zhang, Jiayu
    Zhao, Taincheng
    Tian, Leilei
    Li, Yezhou
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [10] LncRNA PVT1 facilitates DLBCL development via miR-34b-5p/Foxp1 pathway
    Tao, Shi
    Chen, Yu
    Hu, Min
    Xu, Lu
    Fu, Cai-Bo
    Hao, Xin-Bao
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2022, 477 (03) : 951 - 963